EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Design and Preclinical Evaluation of First 68 Ga-Labeled Cathepsin D-Targeted Radiotracers

Yue Xi, Xiangwei Wang, Mengjing Ji, Jianping Zhang, Xiaoping Xu, Simin He, Shaoli Song iD

Journal of Medicinal Chemistry · 2025

DOI: 10.1021/acs.jmedchem.5c02151 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, 2025. Verfasst von Yue Xi und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nuclear Medicine, Fudan University Shanghai Cancer Center; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai…. Hauptthemen laut MEDLINE: Cathepsin D, Gallium Radioisotopes, Radiopharmaceuticals, Drug Design. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Natural Science Foundation of Shanghai Municipality, China Postdoctoral Science Foundation, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cathepsin D (CTSD), a lysosomal aspartic protease linked to cancer progression and poor patient outcomes, is underexplored as a diagnostic biomarker. This study developed the first CTSD-targeted radiotracers, identifying [68Ga]Ga-NOTA-FZCD-3 as optimal due to its strong binding to CTSD (dissociation constant = 0.65 μM), rapid clearance from the body (elimination half-life = 16.61 min), and high tumor-specific uptake in mouse models. Imaging analysis revealed that tumors with higher CTSD levels absorbed more of the tracer, particularly in the MDA-MB-175VII model, which showed the highest tumor uptake (3.63 ± 0.32%ID/g at 0.5 h) and excellent tumor/nontumor contrast (7.65 ± 1.14 at 1 h). The tracer remained stable in blood for over 2 h without causing toxicity. These findings highlight CTSD as a key cancer biomarker and demonstrate the potential of this radiotracer for improving early cancer detection and monitoring therapy response in patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cathepsin DGallium RadioisotopesRadiopharmaceuticalsDrug DesignAnimalsHumansMiceCell Line, TumorFemaleTissue Distribution

Substanzen

Cathepsin DGallium RadioisotopesRadiopharmaceuticals

Autor:innen und Institutionen

  • Department of Nuclear Medicine, Fudan University Shanghai Cancer Center; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, China.
  • Center for Biomedical Imaging, Fudan University, Shanghai 200032, China.
  • Shanghai Engineering Research Center of Molecular Imaging Radiotracers, Shanghai 200032, China.
  • Key Laboratory of Nuclear Physics and Ion-beam Application (MOE), Fudan University, Shanghai 200433, China.

ORCID-Profile: Shaoli Song

Förderung

  • Natural Science Foundation of Shanghai Municipality
  • China Postdoctoral Science Foundation
  • National Natural Science Foundation of China

Zitieren

APA

Xi, Y., Wang, X., Ji, M., Zhang, J., Xu, X., He, S., & Song, S. (2025). Design and Preclinical Evaluation of First 68 Ga-Labeled Cathepsin D-Targeted Radiotracers. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.5c02151

Vancouver

Xi Y, Wang X, Ji M, Zhang J, Xu X, He S, et al. Design and Preclinical Evaluation of First 68 Ga-Labeled Cathepsin D-Targeted Radiotracers. Journal of Medicinal Chemistry. 2025. doi:10.1021/acs.jmedchem.5c02151

BibTeX
@article{Xi2025,
  author = {Xi, Yue and Wang, Xiangwei and Ji, Mengjing and Zhang, Jianping and Xu, Xiaoping and He, Simin and Song, Shaoli},
  title = {Design and Preclinical Evaluation of First 68 Ga-Labeled Cathepsin D-Targeted Radiotracers},
  journal = {Journal of Medicinal Chemistry},
  year = {2025},
  doi = {10.1021/acs.jmedchem.5c02151}
}
Kostenlos starten →